Undergraduate Announcements
New Undergraduate Course Fall 2007
Biol 4790: Current Trends in the Biomedical Industry
The purpose of the seminar series is to bring together undergraduate science and business students to learn how these disciplines merge in companies that commercialize bioscience products. Serving as faculty will be senior executives of pharmaceutical, biotechnology and medical device companies.
The goal of this series is to educate the science and business students who will be the entrepreneurs and senior bioscience company executives of the future. Learning how science and business work together in bioscience companies will give students an advantage over most students whose introduction to this unique interaction usually occurs when they join a company. The course also will make students aware of the many job opportunities available in Georgia. Other benefits include fostering development of an applied technology and business-oriented culture in the universities while training potential management-level employees for local companies.
Instructor: H. Elliott Albers, Ph.D.
290B Kell Hall, 404-651-2946,
biohea@langate.gsu.edu
Course meets every Wednesday from 4 –6 pm.
Location: Georgia Tech Research Institute (GTRI) Conference Center Auditorium,
250 14th Street, NW
Atlanta, Georgia
**except October 31st, location TBD for this date
Directions: http://www.gtri.gatech.edu/visitorinfo/gtriconfdriving.html
NOTE: After the 1st class meeting, you may attend by video-conference from
212 Kell Hall
Class Meeting Topics
August 29th – Dr. Harold Shlevin, President & CEO Tikvah Therapeutics
Initial course meeting of all students and instructors to introduce course.
Overview of Disease
September 5th – Dr. Yashwant Deo, CEO AviGenics, Inc.
Defining “disease” or medical need; Identifying unmet medical needs and markets for products (risk assessment); Criteria for identifying a marketable product to pursue
September 12th – Dr. Julian Bennett, VP New Business Dev. Solvay Pharm. Identifying the ideal characteristics of targeted product; Identifying how the product differs from existing products; Identifying what has already been done or what others are currently doing in this area; How to make money on your product/idea (limitations of market size, limitations of your product output); Identifying the goals for what the product does
September 19th – Dr. Yashwant Deo, CEO AviGenics, Inc.
Gathering information about relevant science (what science has already been done and who is doing the relevant science); Identifying any relevant patents that already exist; Introduction to preclinical and clinical phases of product development
September 26th – Dr. Earl Sands, VP Research & Dev. Solvay Pharm.
Identifying the science that needs to get done and how to do it (what questions to ask and how to answer them)
October 3rd – Dr. Russ Medford, President & CEO, AtheroGenics, Inc.
Interface between Academics and Industry as part of the process of developing a product
October 10th - Dr. Robert McNally, CEO Cell Dynamics, LLC
Preclinical studies: design and implementation (bioinformatics, biostatistics, pharmacokinetics and toxicology, data collection, managing data)
Human dimension: bioinformatics, biostatistics, selecting patients, data collection, managing information, distribution, pharmacokinetics, Phase I trials, link to toxicology studies
October 17th – Dr. Earl Sands, VP Research & Dev. Solvay Pharm.
Clinical studies: design and implementation (regulatory issues for human testing, finding and selecting subjects, data collection, managing data)
October 24th – Dr. Yashwant Deo, CEO AviGenics, Inc.
Review and approval process (from the point of the FDA and product developer)
*October 31st – Dr. Chris Offen, CEO Wynden Pharm.
Marketing practices for product launch (how to communicate information, sales force management)
* class meeting location TBD
November 7th - TBD
Public relations, reimbursement (success attracts attention and take-over offers)
November 14th – Dr. Lawrence Downey, President & CEO, Solvay Pharm.
Current & future trends in industry; Internships for students in participating companies
*November 28th Final course meeting of students and instructors at individual institutions
*class meets in 212 Kell Hall at GSU
|
